Essex Investment Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-12,692
Closed -$382K 386
2017
Q2
$382K Buy
12,692
+2,308
+22% +$69.5K 0.05% 270
2017
Q1
$375K Buy
+10,384
New +$375K 0.06% 285